Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hOKT3gamma1 (Ala-Ala) for the Prevention of Human Islet Allograft Failure
NCT00008801Phase 2Unknown
- Sponsor
- National Center for Research Resources
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of teplizumab in type 1 diabetes mellitus (T1D), diabetes mellitus (DM), sponsored by National Center for Research Resources. Status: unknown.
02
Drugs
teplizumab
03
Conditions
type 1 diabetes mellitus (T1D)diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT00008801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00008801.